2cureX AB (2QE) Stock Statistics & Valuation Metrics

2cureX AB has a market cap or net worth of €6.76M. The enterprise value is €79.46M.

2cureX AB has 25,102,917 shares outstanding. The number of shares has decreased by -2.65% in one year.

2cureX AB’s return on equity (ROE) is -0.81 and return on invested capital (ROIC) is -93.04%.

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.

In the last 12 months, 2cureX AB had revenue of 0.00 and earned -4.13M in profits. Earnings per share was -0.20.

In the last 12 months, operating cash flow was -22.59M and capital expenditures -17.00K, giving a free cash flow of -22.61M billion.

2cureX AB pays an annual dividend of €0.008, resulting in a dividend yield of 3.02%

2cureX AB upcoming earnings date is Aug 21, 2025, TBA (Confirmed).

2cureX AB as a current ratio of 2.93, with Debt / Equity ratio of 0.00%

In the past 12 months, 2cureX AB has paid 0.00 in taxes.

2cureX AB EV to EBITDA ratio is -0.91, with an EV/FCF ratio of -0.81.

2cureX AB has €3.13M in cash and marketable securities with kr0.00 in debt, giving a net cash position of -€3.13M billion.

Gross margin is -173.08%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for 2cureX AB is ―, which is 11.43% higher than the current price. The consensus rating is ―